1
Pediatric Emergencies:What the Primary Care Physician
Should Know Jeremy Jones, DO
Oklahoma State University
Center for Health Sciences
Table of Contents
• Objectives• Practice Gap• Disclosures• Status Epilepticus• Anaphylaxis• Status Asthmaticus
• Questions• Application in Simulation
• Resources
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 2
2
Objectives
• Plan the appropriate initial evaluation of status epilepticus, and manage appropriately
• Recognize the signs and symptoms of anaphylaxis, and manage appropriately
• Provide appropriate treatment for a patient who has an acute exacerbation of asthma, including asthma that is not responsive to adrenergic agonist therapy
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 3
Practice Gap – Status Epilepticus
• The causes of seizures are many, and a number of other conditions can mimic seizures, making careful evaluation of seizure‐like episodes critical.
• Febrile seizures are the most common type of seizure in children, and their management is usually the task of the general pediatrician.
• Status epilepticus constitutes an emergency situation that can have severe consequences and requires skilled therapy.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 4
Reet Sidhu, Kohilavani Velayudam and Gregory Barnes. Pediatric Seizures. Pediatrics in Review 2013;34;333
3
Practice Gap – Anaphylaxis
• Anaphylaxis can cause death; thus, clinicians must be aware of the characteristics of anaphylaxis and of proper therapy, including immediate administration of epinephrine.
• All patients at risk should carry self‐administration epinephrine pens, with 2 epinephrine pens (twin pack) now recommended in case a second dose is needed for persistent symptoms.
• Given the 20% incidence of biphasic latent reactions, patients always should self‐administer epinephrine and seek immediate emergency medical treatment.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 5
Emily W. Langley and Joseph Gigante. Anaphylaxis, Urticaria, and Angioedema. Pediatrics in Review 2013;34;247
Practice Gap – Status Asthmaticus
• Asthma affects the health and quality of life of many children and is a major cause of emergency department visits and hospital admissions.
• Advances in clinical and basic research have not led to a significant reduction in urgent care visits.
• One probable contributor is the lack of universal implementation of asthma guidelines into clinical practice.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 6
Holger Werner Link. Pediatric Asthma in a Nutshell. Pediatrics in Review 2014;35;287
4
DisclosuresNothing to disclose…
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 7
Status Epilepticus
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 8
5
Classification of Status Epilepticus (SE)
26%
33%
1%
3%
22%
15%
Type of SE Acute symptomatic
Remote symptomatic
Remote symptomatic with an acuteprecipitantProgressive encephalopathy
Febrile
Cryptogenic
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 9
J. J. Riviello, Jr, S. Ashwal, D. Hirtz, et al. Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence‐based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67;1542‐1550
EEG Findings in Children with SE
8%
41%
6%
8%
16%
19%
2%
EEG Findings Normal
Generalized slowing
Focal slowing
Epileptiform features, generalized only
Epileptiform features, focal only
Epileptiform features, generalized and focal
Electrocerebral inactivity
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 10
J. J. Riviello, Jr, S. Ashwal, D. Hirtz, et al. Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence‐based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67;1542‐1550
6
Characteristics of Distinct Seizure Phenotypes
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 11
Reet Sidhu, Kohilavani Velayudam and Gregory Barnes. Pediatric Seizures. Pediatrics in Review 2013;34;333
Results of Studies in Which AED Levels Were Obtained
Key NLow AED levels
AED withdrawn or D/C
AEDnoncompliance
Total 528 74 31 1 (0.2%)
Mean, % 32 ± 25 9 ± 10 ‐‐‐
Median, % 21 4.2
Range, % 2.7 – 63 1 – 28 ‐‐‐
95%, CI, % 8.8 – 51 ‐0.5 – 18.6
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 12
J. J. Riviello, Jr, S. Ashwal, D. Hirtz, et al. Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence‐based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67;1542‐1550
7
Doses of Commonly Used Antiepileptic Drugs in Status Epilepticus
Drug Route Dosage
LorazepamIntravenousIntranasal
0.1 mg/kg up to 4 mg total, may repeat in 5‐10 min0.1 mg/kg
Midazolam
Intravenous
IntramuscularIntranasal Buccal
0.2 mg/kg up to 10 mg total dose, may repeat in 5‐10 min0.08‐0.23 mg/kg/hr maintenance0.2 mg/kg0.2 mg/kg0.5 mg/kg
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 13
Mohamad A. Mikati and Abeer J. Hani. Status Epilepticus. 593.8. Nelson Textbook of Pediatrics 20th Edition. Kliegman, Robert M., MD; Stanton, Bonita F., MD; St Geme, Joseph W., MD; Schor, Nina F., MD, PhD. 2016. pp 2854‐2856.
Doses of Commonly Used Antiepileptic Drugs in Status Epilepticus
Drug Route Dosage
Diazepam
Intravenous
Rectal
0.15 mg/kg up to a max total dose of 10 mg, may repeat in 5‐10 min2‐5 yr: 0.5 mg/kg6‐11 yr: 0.3 mg/kg≥12 yr: 0.2 mg/kg
Fosphenytoin Intravenous20 mg/kg PE, then 3‐6 mg/kg/24 hr, loading rate up to 50 mg PE per min
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 14
Mohamad A. Mikati and Abeer J. Hani. Status Epilepticus. 593.8. Nelson Textbook of Pediatrics 20th Edition. Kliegman, Robert M., MD; Stanton, Bonita F., MD; St Geme, Joseph W., MD; Schor, Nina F., MD, PhD. 2016. pp 2854‐2856.
8
Proposed Treatment Algorithm for Status Epilepticus: 0 – 5 Minutes: Stabilization Phase1. Stabilize patient (“ABCD” – neurologic exam)
2. Time seizure from its onset, monitor vital signs
3. Assess oxygenation, give oxygen, consider intubation if needed
4. Initiate ECG monitoring
5. Collect finger stick blood glucose
6. Attempt IV access and collect electrolytes, hematology, toxicology screen, (if appropriate) anticonvulsant drug levels
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 15
Tracy Glauser, MD, et al. Evidence‐Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents, Vol. 16, No. 1 (January/February) 2016 pp. 48–61
Proposed Treatment Algorithm for Status Epilepticus: 5 – 20 Minutes: Initial Therapy Phase
• Choose 1 of the following 3 equivalent first line options• Intramuscular midazolam (10 mg for > 40 kg, 5 mg for 13 – 40 kg, single dose)
• Intravenous lorazepam (0.1 mg/kg/dose, may repeat dose once)
• Intravenous diazepam (0.15 – 0.2 mg/kg/dose, may repeat dose once)
• If none of the 3 options above are available, choose 1:• Intravenous phenobarbital (15 mg/kg/dose, single dose)
• Rectal diazepam (0.2 – 0.5 mg/kg, single dose)
• Intranasal or buccal midazolam
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 16
Tracy Glauser, MD, et al. Evidence‐Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents, Vol. 16, No. 1 (January/February) 2016 pp. 48–61
9
Proposed Treatment Algorithm for Status Epilepticus: 20 – 40 Minutes: Second Therapy Phase
• There is no evidence‐based preferred second therapy of choice
• Choose 1 of the following second line options, give as a single dose• Intravenous fosphenytoin (20 mg PE/kg, single dose)
• Intravenous valproic acid (40 mg/kg, single dose)
• Intravenous levetiracetam (60 mg/kg, single dose)
• If these options above are available, consider (if not already given)• Intravenous phenobarbital (15 mg/kg, single dose)
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 17
Tracy Glauser, MD, et al. Evidence‐Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents, Vol. 16, No. 1 (January/February) 2016 pp. 48–61
Rescue Medicine for Epilepsy in Education Settings – Clinical Report3. An individualized action plan will be most effective if it takes into
consideration the possible options for the least restrictive medication choice (i.e., buccal or nasal route) for the child in his or her environment while ensuring the child’s safety.
4. An individualized action plan can also include details of when to activate emergency medical services, depending on the patient and available resources.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 18
Adam L. Hartman, Cynthia Di Laura Devore, and the SECTION ON NEUROLOGY and COUNCIL ON SCHOOL HEALTH. Rescue Medicine for Epilepsy in Education Settings. Pediatrics 2016;137. originally published online December 28, 2015
10
Anaphylaxis
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 19
Signs and Symptoms of Anaphylaxis
Sign/symptom % Sign/symptom %
Cutaneous Hypotension, dizziness, syncope, diaphoresis
30 – 35Urticaria and angioedema 62 – 90
Flushing 45 – 55 Abdominal
Pruritus without rash 2 – 5 Nausea, vomiting,
diarrhea, abdominal pain25 – 30
Respiratory Miscellaneous
Dyspnea, wheeze 45 – 50 Headache 5 – 8
Upper airway angioedema 50 – 60 Substernal pain 4 – 5
Rhinitis 15 – 20 Seizure 1 – 2
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 20
Phillip Lieberman, MD, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol 115 (2015) 341 – 384.
11
Anaphylaxis: Recognition
• Skin, conjunctivae, oral mucosa: itching, redness, hives, swelling
• Respiratory tract: hoarseness, throat itching, throat tightness, stridor, cough, difficulty breathing, chest tightness, wheeze, cyanosis;
• Cardiovascular symptoms: tachycardia, chest pain, hypotension, weak pulse, dizziness, collapse, incontinence, shock;
• Gastrointestinal tract symptoms: nausea, crampy abdominal pain, persistent vomiting, diarrhea
• Central nervous system: behavioral changes (infants), sense of doom, headache, altered mental status, confusion, tunnel vision.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 21
Scott H. Sicherer, F. Estelle R. Simons and SECTION ON ALLERGY AND IMUNOLOGY. Epinephrine for First‐aid Management of Anaphylaxis. Pediatrics 2017;139;; originally published online February 13, 2017
Symptoms and Signs of Anaphylaxis in Infants
System Sign
SKIN/MUCUS MEMBRANESRapid onset of hives (potentially difficult to discern in infants with acute atopic dermatitis; scratching and excoriations will be absent in young infants); angioedema (face, tongue, oropharynx)
RESPIRATORYRapid onset of coughing, choking, stridor, wheezing, dyspnea, apnea, cyanosis
GASTROINTESTINAL Sudden, profuse vomiting
CARDIOVASCULARWeak pulse, arrhythmia, diaphoresis/ sweating, collapse/unconsciousness
CENTRAL NERVOUS SYSTEM Rapid onset of unresponsiveness, lethargy, or hypotonia; seizures
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 22
Adapted from Simons FER. Anaphylaxis in infants: can recognition and management be improved? J Allergy ClinImmunol 120:537–540, 2007.
12
Patient Factors That Contribute to Anaphylaxis
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 23
Simons FER, Ardusso LRF, Bilo MB, El‐Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization Anaphylaxis Guidelines: Summary. J Allergy Clin Immunol. 2011;127(3):587–93. e1‐e20.
Anaphylaxis Mechanisms and Triggers
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 24
Simons FER, Ardusso LRF, Bilo MB, El‐Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization Anaphylaxis Guidelines: Summary. J Allergy Clin Immunol. 2011;127(3):587–93. e1‐e20.
13
Causes of Anaphylaxis
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 25
Emily W. Langley and Joseph Gigante. Anaphylaxis, Urticaria, and Angioedema. Pediatrics in Review 2013;34;247
Anaphylaxis Triggers
• Anaphylaxis triggers• Across all age groups, the most common are
• Ingested foods (33%)
• Insect stings (19%)
• Medications (14%)
• Hereditary angioedema• Consider when angioedema occurs in the absence of urticaria
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 26
14
Role of Laboratory Tests in the Diagnosis of Anaphylaxis• Total tryptase (pro, pro’, and mature forms of α/β tryptases)
• Obtain blood sample within 15 minutes to 3 hours of symptom onset
• Consider measuring levels in accurately timed serial blood samples during the anaphylactic episode
• Consider comparing levels measured during the episode with a baseline level
• Histamine• Obtain blood sample within 15 minutes to 1 hour of symptom onset
• Measure histamine and its metabolite N‐methylhistamine in a 24‐hour urine sample
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 27
Simons FER, Ardusso LRF, Bilo MB, El‐Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization Anaphylaxis Guidelines: Summary. J Allergy Clin Immunol. 2011;127(3):587–93. e1‐e20.
Diagnosis of Anaphylaxis
• Anaphylaxis is highly likely when any 1 of the following 3 criteria is fulfilled:
1. Acute onset of an illness (minutes to several hours) with involvement of the skin and/or mucosal tissue
AND AT LEAST 1 OF THE FOLLOWING: a. Respiratory compromise
b. Reduced BP or associated symptoms of end‐organ dysfunction
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 28
Modified from Sampson HA, Muñoz‐Furlong A, Campbell RL, et al: Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol 117:391–397, 2006.
15
Diagnosis of Anaphylaxis
• Anaphylaxis is highly likely when any 1 of the following 3 criteria is fulfilled:
2. Two or more of the following that occur rapidly after exposure to a likely allergen for that patient (minutes to several hours): a. Involvement of the skin/mucosal tissue
b. Respiratory compromise
c. Reduced BP or associated symptoms
d. Persistent gastrointestinal symptoms
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 29
Modified from Sampson HA, Muñoz‐Furlong A, Campbell RL, et al: Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol 117:391–397, 2006.
Diagnosis of Anaphylaxis
• Anaphylaxis is highly likely when any 1 of the following 3 criteria is fulfilled:
3. Reduced BP following exposure to known allergen for that patient (minutes to several hours): a. Infants, children: low systolic BP (age‐specific) or >30% drop in systolic BP
b. Adults: systolic BP <90 mm Hg or >30% drop from patient’s baseline
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 30
Modified from Sampson HA, Muñoz‐Furlong A, Campbell RL, et al: Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol 117:391–397, 2006.
16
Anaphylaxis: First‐aid Treatment
1. Be prepared! Have a written anaphylaxis emergency action plan.
2. When anaphylaxis occurs, promptly assess the patient’s airway, breathing, circulation, and skin and call for help: 911 or EMS.
3. Inject epinephrine (adrenaline) IM. If needed, give a second injection 5 to 15 minutes after the first.
4. Place the patient on his or her back or in a position of comfort.
5. Transport the patient to an emergency department, preferably by an EMS vehicle, for further assessment and monitoring. Additional treatment, including supplemental oxygen, intravenous fluids, and other interventions may be needed.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 31
Scott H. Sicherer, F. Estelle R. Simons and SECTION ON ALLERGY AND IMUNOLOGY. Epinephrine for First‐aid Management of Anaphylaxis. Pediatrics 2017;139;; originally published online February 13, 2017
Anaphylaxis Treatment Protocol – MedicationsOptional treatment (efficacy has not been established)
H1 antihistamineConsider giving 1 mg/kg diphenhydramine IV (maximum 50 mg) for childrenUse 10 mg of cetirizine if an oral antihistamine is administered
CorticosteroidsAdminister 1 – 2 mg/kg up to 125 mg per dose, IV or PO, of methylprednisolone or an equivalent formulation
Observation and monitoring
Observation in hospital
Transport to emergency department by EMS for further treatment and observation for ± 8 h
Observation in office
Observe in office until full recovery + additional 30 –60 min for all patients who are not candidates for EMS transport to emergency department
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 32
Phillip Lieberman, MD, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol 115 (2015) 341 – 384.
17
Anaphylaxis Treatment Protocol – Discharge ManagementDischarge management
EducationEducate patient and family on how to recognize and how to treat anaphylaxis
Auto‐injectable epinephrine
Prescribe 2 doses of auto‐injectable epinephrine for patients who have experienced an anaphylactic reaction and for those at risk for severe anaphylaxis; train patient, patient provider, and family on how to use the auto‐injector
Anaphylaxis action plan
Provide patients with an action plan instructing them on how and when to administer epinephrine
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 33
Phillip Lieberman, MD, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol 115 (2015) 341 – 384.
Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 34
Julie Wang, Scott H. Sichererand SECTION ON ALLERGY AND IMMUNOLOGY. Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan. Pediatrics 2017;139;; originally published online February 13, 2017
18
Anaphylaxis Emergency Plan Summary
2. An allergy and anaphylaxis emergency plan, developed by the health care provider, would be beneficial for patients who are at risk of anaphylaxis and those who have been prescribed an epinephrine autoinjector.
3. The written plan may serve as a guide for patients, family and nonfamily caregivers, and school personnel in the management of allergic reactions.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 35
Julie Wang, Scott H. Sicherer and SECTION ON ALLERGY AND IMMUNOLOGY. Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan. Pediatrics 2017;139;; originally published online February 13, 2017
Status Asthmaticus
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 36
19
Demographics
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 37
• Over 10 million school days missed due to asthma• Over $50 billion spent annually by the healthcare
system due to asthma
Andrew H. Liu, Ronina A. Covar, Joseph D. Spahn, and Scott H. Sicherer. Childhood Asthma. 144. Nelson Textbook of Pediatrics 20th Edition. Kliegman, Robert M., MD; Stanton, Bonita F., MD; St Geme, Joseph W., MD; Schor, Nina F., MD, PhD. 2016. pp 1095‐1115.
Stepwise Approach for Asthma Therapy – Preferred TreatmentAge, y STEP 1 STEP 2 STEP 3 STEP 4 STEP 5 STEP 6
0 – 4 SABA
as neededLow‐dose
ICSMedium‐dose ICS
Medium‐dose ICS and LABA
High‐dose ICS and LABA
STEP 5 and OCS
5 – 11 SABA
as neededLow‐dose
ICS
Low‐dose ICS and LABA
Medium‐dose ICS and LABA
High‐dose ICS and LABA
STEP 5 and OCS
≥ 12SABA
as neededLow‐dose
ICS
Low‐dose ICS and LABA
Medium‐dose ICS and LABA
High‐dose ICS and LABA
STEP 5 and OCS
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 38
Adapted from the National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. NIH publication 07‐4051.
20
Stepwise Approach to Asthma Management
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 39
Asthma Exacerbations Initial Management
• Initial management • Decreasing airway obstruction
• Correcting hypoxemia
• Preventing further progression of symptoms
• Immediate goals• Close patient monitoring
• Oxygen supplementation to maintain oxygen saturation at 90% or greater
• Administration of bronchodilators
• Inhaled beta2‐agonist• Nebulization or an MDI
• Administered every 20 minutes for 1 hour should be the initial therapy
• Inhaled anticholinergics• Have been shown to improve lung function and reduce hospitalization rates IF
• Must be given with the first three albuterol treatments
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 40
21
Asthma Exacerbations Severity Treatment
02:17:16 717 S Houston Ave Ste 502, Tulsa, OK 74127‐9022 41
Pediatric Asthma Score
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 42
Theresa A. Walls, Naomi T. Hughes, Paul C. Mullan, James M. Chamberlain and Kathleen Brown. Improving Pediatric Asthma Outcomes in a Community Emergency Department. Pediatrics 2017;139;; originally published online December 8, 2016.
22
Asthma Pathway for Community Emergency Department• Triage order set
• Nursing interventions• Continuous pulse ox monitoring
• Peripheral IV start
• Medications
• For patients < 30 kg• Continuous ipratropium 0.5 mg x 1
• Continuous albuterol 7.5 mg x 1
• For patients > 30 kg• Continuous ipratropium 1 mg x 1
• Continuous albuterol 15 mg x 1
• Dexamethasone• 6 mg for patients 6 – 10 kg PO
• 10 mg for patients 11 – 20 kg PO
• 16 mg for patients 21 kg and above PO
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 43
Theresa A. Walls, Naomi T. Hughes, Paul C. Mullan, James M. Chamberlain and Kathleen Brown. Improving Pediatric Asthma Outcomes in a Community Emergency Department. Pediatrics 2017;139;; originally published online December 8, 2016.
Asthma Pathway for Community Emergency Department• Provider order set (in addition to triage to nursing set)
• Additional interventions• Consider consult other facility
• Additional medications• Magnesium sulfate
• Epinephrine
• Methylprednisolone
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 44
Theresa A. Walls, Naomi T. Hughes, Paul C. Mullan, James M. Chamberlain and Kathleen Brown. Improving Pediatric Asthma Outcomes in a Community Emergency Department. Pediatrics 2017;139;; originally published online December 8, 2016.
23
Asthma Action Plan
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 45
SIGN 153 – British guideline on the management of asthma. A National Clinical Guideline. September 2016.
Questions…
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 46
24
Status Epilepticus
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 47
PREP 2009 Question 150
• A 14‐year‐old boy who has epilepsy presents to the emergency department after a generalized tonic‐clonic seizure that began on the playground at school.
• He continued to convulse en route in the ambulance, where he received 15 mg diazepam rectally and intravenous access was achieved.
• In the emergency department, he continues to be unresponsive, exhibiting tachycardia and non‐suppressable bilateral synchronous rhythmic clonic jerks.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 48
25
150., 2
• Of the following, the MOST appropriate medication to administer next isA. fosphenytoin 20 mg/kg intravenously
B. pentobarbital 5 mg/kg intravenously
C. phenobarbital 20 mg/kg intravenously
D. phenytoin 7 mg/kg orally
E. valproic acid 15 mg/kg intravenously
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 49
PREP 2010 Question 102
• A 17‐year‐old boy is brought via ambulance to the emergency department due to a generalized tonic‐clonic seizure that is ongoing.
• No medications have been administered en route, but intravenous access has been obtained.
• After administration of 2 mg intravenous lorazepam, the seizure stops.
• According to his father, the boy has epilepsy that is difficult to control, for which he takes valproic acid, oxcarbazepine, and levetiracetam.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 50
26
102., 2
• Of the following, the MOST appropriate next diagnostic test to obtain isA. brain magnetic resonance imaging
B. electroencephalography
C. measurement of blood anticonvulsant concentrations
D. measurement of serum calcium, magnesium, and phosphorous
E. measurement of serum electrolytes
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 51
Anaphylaxis
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 52
27
PREP 2014 Question 159
• A 2‐year‐old is in the ER for rash and swelling of her lips.
• She ate a peanut butter cracker before arrival and started choking.
• The girl then developed hives on her face.
• Her mother gave her diphenhydramine, and the hives faded, but symptoms progressed to include lip swelling and a raspy voice.
• Now the girl is irritable and appears to be breathing fast.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 53
159., 2
• The MOST appropriate step in this girl’s management is to administerA. Injectable corticosteroid
B. Injectable epinephrine
C. Nebulized albuterol
D. Ranitidine and diphenhydramine
E. Scheduled diphenhydramine
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 54
28
PREP 2014 Question 213
• A 3‐year‐old girl is seen after hospital discharge.
• A few days ago, she developed an erythematous, itchy, raised, blotchy rash, marked swelling of the eyes and lips, and raspy breathing.
• The child was given injectable epinephrine, diphenhydramine, and systemic corticosteroids.
• The symptoms improved, but the child was admitted to be observed overnight.
• The mother would like you to determine what triggered this reaction.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 55
213., 2
• The MOST common triggers for events such as those experienced by this girl areA. Aeroallergens, contact allergens, latex, cleaning agents
B. Foods, medications, hereditary angioedema, idiopathic triggers
C. Infections (viral or bacterial), foods, medications, insect stings
D. Mast cell disorders, hereditary angioedema, urticarial vasculitis
E. Nonsteroidal anti‐inflammatory drugs, antibiotics, narcotics, and radiocontrast media
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 56
29
Status Asthmaticus
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 57
PREP 2014 Question 195
• A 7‐year‐old boy has been “coughing and wheezing since dinner last night.”
• He required 2 albuterol treatments last night and 3 treatments since early this morning.
• The child is sitting upright and appears breathless.
• Vitals reveal T 37.1 oC, SaO2 82% on room air, HR 120 bpm, and RR 40 rpm.
• He is using accessory muscles to breathe
• Lung sounds are diminished bilaterally with mild wheezing.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 58
30
195, 2
• He is barely able to speak.
• His peak expiratory flow is 35% of predicted.
• The MOST likely initial diagnosis isA. Acute moderate asthma exacerbation
B. Acute severe asthma exacerbation
C. Foreign body aspiration
D. Pneumonia
E. Pneumothorax
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 59
PREP 2014 Question 71
• A 9‐year‐old girl is in the emergency room (ER) for an asthma exacerbation.
• At home, she had back to back to back albuterol breathing treatments.
• On your examination, vitals reveal RR 40 rpm and SaO2 92% on room air.
• There are intercostal and suprasternal retractions and bilateral wheezes.
• Peak expiratory flow is 40% of predicted value.• You give her another albuterol treatment.
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 60
31
71., 2
• The best NEXT step in management is toA. Add ipratropium bromide to the albuterol
B. Observe her to assess response to albuterol
C. Order a heliox administration
D. Order a loading dose of an oral corticosteroid
E. Order a subcutaneous terbutaline
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 61
Application in Simulation at OSU‐CHS– Special ThanksMatt Tucker, DO
Shelley Houk
David Knight
Sarah White
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 62
32
ResourcesPediatric Review Education Program
American Academy of Pediatrics
Hugh A. Sampson, Julie Wang, and Scott H. Sicherer. Anaphylaxis. 149. Nelson Textbook of Pediatrics 20th Edition. Kliegman, Robert M., MD; Stanton, Bonita F., MD; St Geme, Joseph W., MD; Schor, Nina F., MD,
PhD. 2016. pp 1131‐1136.
References – Status Epilepticus
• Riviello JJ Jr, Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2006;67:1542‐1550. Available at: http://www.neurology.org/cgi/content/full/67/9/1542
• Riviello JJ Jr, Holmes GL. The treatment of status epilepticus. SeminPediatr Neurol. 2004;11:129‐138. Abstract available at: http://www.ncbi.nlm.nih.gov/pubmed/15259866
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 64
33
References – Status Epilepticus
• Major P, Thiele EA. Seizures in children: laboratory diagnosis and management. Pediatr Rev. 2007;28:405‐414. Available at: http://pedsinreview.aappublications.org/cgi/content/full/28/11/405
• Walker DM, Teach SJ. Update on the acute management of status epilepticus in children. Curr Opin Pediatr. 2006;18:239‐244. Abstract available at: http://www.ncbi.nlm.nih.gov/pubmed/16721142
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 65
References – Acute Exacerbation of Asthma
• Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomisedcontrolled trial. Lancet. 2004;363:271‐275. Abstract available at: http://www.ncbi.nlm.nih.gov/pubmed/14751699
• Keeley D, McKean M. Asthma and other wheezing disorders in children. BMJ Clinical Evidence. 2006. Available for subscription at: http://clinicalevidence.bmj.com/ceweb/conditions/chd/0302/0302.jsp830Q1
• National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR‐3): Guidelines for the Diagnosis and Management of Asthma‐Summary Report 2007. J Allergy Clin Immunol. 2007;120:S94‐S138. Abstract available at: http://www.ncbi.nlm.nih.gov/pubmed/17983880
09:30:17 717 S Houston Ave, Ste 502, Tulsa, OK 74127‐9023 66